Duration of Symptoms and Plasma Cytokine Levels in Patients with the Common Cold Treated with Zinc Acetate: A Randomized, Double-Blind, Placebo-Controlled Trial
The DOI matches its Crossref record; 39 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Adults and children in the United States get two to six colds per year. Evidence that zinc is effective therapy for colds is inconsistent. OBJECTIVE: To test the efficacy of zinc acetate lozenges in reducing the duration of symptoms of the common cold. DESIGN: Randomized, double-blind, placebo-controlled trial. SETTING: Detroit Medical Center, Detroit, Michigan. PATIENTS: 50 ambulatory volunteers recruited within 24 hours of developing symptoms of the common cold. INTERVENTION: Participants took one lozenge containing 12.8 mg of zinc acetate or placebo every 2 to 3 hours while awake as long as they had cold symptoms. MEASUREMENTS: Subjective symptom scores for sore throat, nasal discharge, nasal congestion, sneezing, cough, scratchy throat, hoarseness, muscle ache, fever, and headache were recorded daily for 12 days. Plasma zinc and proinflammatory cytokine levels were measured on day 1 and after participants were well. RESULTS: Forty-eight participants completed the study (25 in the zinc group and 23 in the placebo group). Compared with the placebo group, the zinc group had shorter mean overall duration of cold symptoms (4.5 vs. 8.1 days), cough (3.1 [95% CI, 2.1 to 4.1] vs. 6.3 [CI, 4.9 to 7.7] days), and nasal discharge (4.1 [CI, 3.3 to 4.9] vs. 5.8 [CI, 4.3 to 7.3] days) and decreased total severity scores for all symptoms (P < 0.002, test for treatment x time interaction). Mean changes in soluble interleukin-1 receptor antagonist level differed nonsignificantly between the zinc group and the placebo group (difference between changes, -89.4 pg/mL [CI, -243.6 to -64.8 pg/mL]). CONCLUSION: Administration of zinc lozenges was associated with reduced duration and severity of cold symptoms, especially cough. Improvement in clinical symptoms with zinc treatment may be related to a decrease in proinflammatory cytokine levels; however, in this study, the observed differences between changes in cytokine levels in zinc and placebo recipients were not significant.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the effect of zinc on the common cold remains controversial, in our studies in patients with common cold, the duration and severity of cold symptoms were Ȃ50% less in zinc-treated subjects than in placebo group subjects (35).”
From Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress (2007) · cites this paper as [35]
In the citing paper
“Human rhinovirus type 24 “docks” with ICAM-1 on the surface of the somatic cells (59, 60).”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [59]
Citations
Cites
Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127
Interleukin 1 receptor antagonist. A new member of the interleukin 1 family.
Arend, W. P. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115453 · Cited by 595
Neopterin as a marker for activated cell-mediated immunity: Application in HIV infection
Fuchs, D., Hausen, A., Reibnegger, G., Werner, E. R., Dierich, M. P., & Wachter, H. (1988) · Immunology Today · doi:10.1016/0167-5699(88)91203-0 · Cited by 563
Beck, F. W., Prasad, A. S., Kaplan, J., Fitzgerald, J. T., & Brewer, G. J. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.272.6.e1002 · Cited by 345
Self-citationRhinovirus Infections in an Industrial Population: The Occurrence of Illness
Gwaltney, J. M., Hendley, J. O., Simon, G., & Jordan, W. S. (1966) · New England Journal of Medicine · doi:10.1056/nejm196612082752301 · Cited by 338 · cited 2×
“dults and children in the United States experience two to six colds per year (1, 2 ). The morbidity and loss of working hours due to the common cold are substantial (1‐3), and treatment remains elusive.”
BackgroundIllness in the home : a study of 25,000 illnesses in a group of Cleveland families
Dingle, J. H., Badger, G. F., & Jordan, W. S. (1964) · Cited by 275
Nasal Cytokine Production In Viral Acute Upper Respiratory Infection Of Childhood
Noah, T. L., Henderson, F. W., Wortman, I. A., Devlin, R. B., Handy, J., Koren, H. S., & Becker, S. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.3.584 · Cited by 258
Mossad, S. B., Macknin, M. L., Mendendorp, S. V., & Mason, P. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-2-199607150-00001 · Cited by 222 · cited 1×
“Proper blinding during a trial is important for interpretation of results (21).”
BackgroundReduction in duration of common colds by zinc gluconate lozenges in a double-blind study
Eby, G. A., Davis, D. R., & Halcomb, W. W. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.25.1.20 · Cited by 217
Turner, R. B., Wecker, M. T., Pohl, G., Witek, T. J., McNally, E., St. George, R., Winther, B., & Hayden, F. G. (1999) · JAMA · doi:10.1001/jama.281.19.1797 · Cited by 206 · cited 2×
“Tremacamra, a soluble intercellular adhesion molecule 1 drug that functions as receptor blockade, was recently used to treat experimentally induced rhinovirus infection (36).”
Background
Research works printed but not linked: 4
- Weismann E, 1990, Dan Med Bull, 37, 279
- Koch AE, 1995, J Invest Med, 43, 28
- Pitkaranta A, 1998, Infections in Medicine, 15, 50
- Beck FW, 1997, Am J Physiol, 272, E1002
Cited by
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835
“Prasad and colleagues (63) reported a placebo-controlled trial of zinc lozenges for reducing the duration of symptoms of the common cold.”
BackgroundCopper, oxidative stress, and human health
Uriu-Adams, J. Y., & Keen, C. L. (2005) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.07.015 · Cited by 975
“While short-term use (4–5 d) of high doses of Zn (80 mg/d) is unlikely to cause Cu deficiency (Prasad et al., 2000), indiscriminate overuse of Zn supplements, or inadvertent high Zn ingestion can result in a Cu deficiency characterized by pancytopenia and neurological complications (Rowin and Lewis, 2005; Willis et al.”
BackgroundDiscovery of Human Zinc Deficiency: Its Impact on Human Health and Disease
Prasad, A. S. (2013) · Advances in Nutrition · doi:10.3945/an.112.003210 · Cited by 919
Self-citationThe Semantics of Microglia Activation: Neuroinflammation, Homeostasis, and Stress
Woodburn, S. C., Bollinger, J. L., & Wohleb, E. S. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02309-6 · Cited by 783
The Role of Zinc in Antiviral Immunity
Read, S. A., Obeid, S., Ahlenstiel, C., & Ahlenstiel, G. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz013 · Cited by 749
Metadata
- Authors
- Prasad, A. S., Fitzgerald, J. T., Bao, B., Beck, F. W. J., & Chandrasekar, P. H.
- Affiliations
- Wayne State University (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2000-08-15
- Volume
- 133
- Issue
- 4
- Pages
- 245-252
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2093316627
- Cited by
- 228
- References
- 41
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 3 · 2022: 13 · 2021: 9 · 2020: 19 · 2019: 8 · 2018: 2 · 2017: 4 · 2016: 6 · 2015: 11 · 2014: 10 · 2013: 3 · 2012: 3
- FWCI
- 32.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Herbal Medicine Research Studies
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pediatric health and respiratory diseases
- Keywords
- common cold, zinc acetate, zinc lozenges, symptom duration, symptom severity, cough, rhinorrhea, inflammatory cytokines, interleukin-1 receptor antagonist, plasma zinc, zinc supplementation
- MeSH terms
- Adult, Common Cold, Cough, Double-Blind Method, Female, Humans, Male, Nasal Mucosa, Placebos, Research Design, Cytokines, Treatment Outcome, Receptors, Interleukin-1, Receptors, Tumor Necrosis Factor, Zinc Acetate, Neopterin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Duration of Symptoms and Plasma Cytokine Levels in Patients with the Common Cold Treated with Zinc Acetate: A Randomized, Double-Blind, Placebo-Controlled Trial. https://app.cochat.ai/papers/10.7326/0003-4819-133-4-200008150-00006
- The paper
- Prasad, A. S., Fitzgerald, J. T., Bao, B., Beck, F. W. J., & Chandrasekar, P. H. (2000). Duration of Symptoms and Plasma Cytokine Levels in Patients with the Common Cold Treated with Zinc Acetate: A Randomized, Double-Blind, Placebo-Controlled Trial. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-133-4-200008150-00006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.